Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 4, 2014, Pages 355-365

  You, Lili ^a   Liu, Aiping ^a   Wuyun, Gaowa ^b   Wu, Heping ^b   Wang, Peiyu ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Hospital of Xilinguole Meng   (China)

Author keywords

Hyperuricemia; Metabolic syndrome; Serum uric acid

Indexed keywords

TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTOR; WAIST CIRCUMFERENCE; BLOOD; COMPLICATION; MIDDLE AGED; MONGOLIA; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERURICEMIA; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MONGOLIA; SEX FACTORS; URIC ACID; YOUNG ADULT;

EID: 84899416515     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.20529     Document Type: Article

References (61)

1. Yu L, Liu X, Gao X: Investigation on prevalence of metabolic syndrome and its risk factors in mongolian people of tongliao city. Chin J Public Health, 2008; 24: 1186-1188
2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SJ: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation, 2009; 120: 1640-1645
3. Kojima C, Takei T, Ogawa T, Nitta K: Serum complement c3 predicts renal arteriolosclerosis in non-diabetic chronic kidney disease. J Atheroscler Thromb, 2012; 19: 854-861
4. Xiong Z, Zhu C, Zheng Z, Wang M, Wu Z, Chen L, Chen Y: Relationship between arterial stiffness assessed by brachial-ankle pulse wave velocity and coronary artery disease severity assessed by the syntax score. J Atheroscler Thromb, 2012; 19: 970-976
5. Rho YH, Woo JH, Choi SJ, Lee YH, Ji JD, Song GG: Association between serum uric acid and the adult treatment panel iii-defined metabolic syndrome: results from a single hospital database. Metabolism, 2008; 57: 71-76
6. Numata T, Miyatake N, Wada J, Makino H: Comparison of serum uric acid levels between japanese with and without metabolic syndrome. Diabetes Res Clin Pract, 2008; 80: e1-e5
7. Cohen E, Krause I, Fraser A, Goldberg E, Garty M: Hyperuricemia and metabolic syndrome: lessons from a large cohort from israel. Isr Med Assoc J, 2012; 14: 676-680
8. Grassi D, Ferri L, Desideri G, Di Giosia P, Cheli P, Del PR, Properzi G, Ferri C: Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des, 2012; 33: 429-432
9. Wu YQ, Li J, Xu YX, Wang YL, Luo YY, Hu DY, Liu WJ, Yang M, Pi L, Wang MS, Wang JY, Zhao SM, Li MJ: Predictive value of serum uric acid on cardiovascular disease and all-cause mortality in urban chinese patients. Chin Med J (Engl), 2010; 123: 1387-1391
10. Kuwahata S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, Orihara K, Ogawa M, Oketani N, Saihara K, Okui H, Shinsato T, Kubozono T, Ichiki H, Fujita S, Takumi T, Yoshino S, Nakazaki M, Miyata M, Tei C: Effect of uric acid on coronary microvascular endothelial function in women: association with egfr and adma. J Atheroscler Thromb, 2010; 17: 259-269
11. Chang CH, Chen YM, Chuang YW, Liao SC, Lin CS, Tang YJ, Sheu WH, Chen DY: Relationship between hyperuricemia (huc) and metabolic syndrome (ms) in institutionalized elderly men. Arch Gerontol Geriatr, 2009; 49 Suppl 2: S46-S49
12. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH: Serum uric acid level as an independent risk factor for allcause, cardiovascular, and ischemic stroke mortality: a chinese cohort study. Arthritis Rheum, 2009; 61: 225-232
13. Chu NF, Wang DJ, Liou SH, Shieh SM: Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in taiwan. Eur J Epidemiol, 2000; 16: 13-17
14. Chuang SY, Chen JH, Yeh WT, Wu CC, Pan WH: Hyperuricemia and increased risk of ischemic heart disease in a large chinese cohort. Int J Cardiol, 2012; 154: 316-321
15. Lin JD, Chiou WK, Chang HY, Liu FH, Weng HF: Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid. Metabolism, 2007; 56: 751-756
16. Yeh TK, Yeh TC, Weng CF, Shih BF, Tsao HJ, Hsiao CH, Chuang FT, Hu CY, Chang CY: Association of polymorphisms in genes involved in the dopaminergic pathway with blood pressure and uric acid levels in chinese females. J Neural Transm, 2010; 117: 1371-1376
17. Cai Z, Xu X, Wu X, Zhou C, Li D: Hyperuricemia and the metabolic syndrome in hangzhou. Asia Pac J Clin Nutr, 2009; 18: 81-87
18. Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J: The prevalence of hyperuricemia in a population of the coastal city of qingdao, china. J Rheumatol, 2006; 33: 1346-1350
19. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality the nhanes i epidemiologic follow-up study, 1971-1992. National health and nutrition examination survey. JAMA, 2000; 283: 2404-2410
20. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN: Uric acid and the development of metabolic syndrome in women and men. Metabolism, 2008; 57: 845-852
21. Choo V: Who reassesses appropriate body-mass index for asian populations. Lancet, 2002; 360: 235
22. Lu ZS, Lu ZH, Lu H, Yan SG, Wang JA, Li L, You W: Association between hyperuricemia and hypertension in a chinese population at a high risk of hypertension. Blood Press, 2009; 18: 268-272
23. Woo J, Swaminathan R, Cockram C, Lau E, Chan A: Association between serum uric acid and some cardiovascular risk factors in a chinese population. Postgrad Med J, 1994; 70: 486-491
24. Zhao LJ, Zhao D, Liu J, Wang W, Wu GX, Qin LP, Liu J, Liu S, Wang WH, Zeng ZC: [association between serum uric acid and triglyceride in a chinese community]. Zhonghua Nei Ke Za Zhi, 2005; 44: 664-667
25. Zhang Q, Lou S, Meng Z, Ren X: Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in chinese. Clin Rheumatol, 2011; 30: 777-787
26. Lin WY, Liu CS, Li TC, Lin T, Chen W, Chen CC, Li CI, Lin CC: In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in chinese populations: a population-based study (taichung community health study). Ann Rheum Dis, 2008; 67: 432-433
27. Nan H, Qiao Q, Soderberg S, Gao W, Zimmet P, Shaw J, Alberti G, Dong Y, Uusitalo U, Pauvaday V, Chitson P, Tuomilehto J: Serum uric acid and components of the metabolic syndrome in non-diabetic populations in mauritian indians and creoles and in chinese in qingdao, china. Metab Syndr Relat Disord, 2008; 6: 47-57
28. Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H: Serum uric acid and its correlates in chinese adult populations, urban and rural, of beijing. The prc-usa collaborative study in cardiovascular and cardiopulmonary epide miology. Int J Epidemiol, 1997; 26: 288-296
29. Liang J, Xue Y, Zou C, Zhang T, Song H, Qi L: Serum uric acid and prehypertension among chinese adults. J Hypertens, 2009; 27: 1761-1765
30. Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, Chien KL, Hwang LC, Su TC, Tseng CH, Sun CA: Uric acid level as a risk marker for metabolic syndrome: a chinese cohort study. Atherosclerosis, 2012; 220: 525-531
31. Villegas R, Xiang YB, Cai Q, Fazio S, Linton M, Li H, Elasy T, Zheng W, Shu XO: Prevalence and determinants of hyperuricemia in middle-aged, urban chinese men. Metab Syndr Relat Disord, 2010; 8: 263-270
32. Hara S, Tsuji H, Ohmoto Y, Amakawa K, Hsieh SD, Arase Y, Nakajima H: High serum uric acid level and low urine ph as predictors of metabolic syndrome: a retrospective cohort study in a japanese urban population. Metabolism, 2012; 61: 281-288
33. Zhang Z, Bian L, Choi Y: Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in korean men. Angiology, 2012; 63: 420-428
34. Tomiyama H, Higashi Y, Takase B, Node K, Sata M, Inoue T, Ishibashi Y, Ueda S, Shimada K, Yamashina A: Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens, 2011; 24: 770-774
35. Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R: Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol, 2011; 10: 72
36. Pacifico L, Cantisani V, Anania C, Bonaiuto E, Martino F, Pascone R, Chiesa C: Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children. Eur J Endocrinol, 2009; 160: 45-52
37. Lu Z, Dong B, Wu H, Chen T, Zhang Y, Wu J, Xiao H: Serum uric acid level in primary hypertension among chinese nonagenarians/centenarians. J Hum Hypertens, 2009; 23: 113-121
38. Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T: Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet 1999; 354: 650
39. Anton FM, Garcia PJ, Ramos T, Gonzalez P, Ordas J: Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (e2) on the renal handling of urate. Metabolism, 1986; 35: 343-348
40. Chuang SY, Lee SC, Hsieh YT, Pan WH: Trends in hyperuricemia and gout prevalence: nutrition and health survey in taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr, 2011; 20: 301-308
41. Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S: Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in okinawa, japan. Hypertens Res, 2004; 27: 227-233
42. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M: Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. Bmc Public Health, 2004; 4: 9
43. Yin JH, Song ZY, Shan PF, Xu J, Ye ZM, Xu XH, Zhang SZ, Liang Q, Zhao Y, Ren Z, Yu YP: Age-and gender-specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in hangzhou, china. Clin Endocrinol (Oxf), 2012; 76: 802-809
44. Chen B, Yang D, Chen Y, Xu W, Ye B, Ni Z: The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of china. Clin Chim Acta, 2010; 411: 705-709
45. Li SL, Yang Q, Lv SY, Zhang YL, Zhang JA: Prevalence of the metabolic syndrome in the yan-an region of northwest china. J Int Med Res, 2012; 40: 673-680
46. Li JB, Wang X, Zhang JX, Gu P, Zhang X, Chen CX, Guo R, Wu M: Metabolic syndrome: prevalence and risk factors in southern china. J Int Med Res, 2010; 38: 1142-1148
47. Lao XQ, Zhang YH, Wong MC, Xu YJ, Xu HF, Nie SP, Ma WJ, Thomas GN, Yu IT: The prevalence of metabolic syndrome and cardiovascular risk factors in adults in southern china. Bmc Public Health, 2012; 12: 64
48. Wuyun GW, Huang YX, Wu HP, Su XL, Wang PY, You LL, Liu AP: Survey on the Prevalence of Common Chronic Diseases among the Mongolian Nomads and Farmers in the Inner Mongolia. Chinese J of Preventive and Control of Chronic Diseases,2011; 19: 448-451
49. Zhou BF: Predictive values of body mass index and waist circumference for risk factors of certain related diseases in chinese adults--study on optimal cut-off points of body mass index and waist circumference in chinese adults. Biomed Environ Sci, 2002; 15: 83-96
50. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, Travia D, Zenti MG, Branzi P, Santi L, Muggeo M: Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The verona young men atherosclerosis risk factors study. Int J Obes Relat Metab Disord, 1996; 20: 975-980
51. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST: Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The normative aging study. Am J Epidemiol, 1995; 142: 288-294
52. Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y: Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism, 1998; 47: 929-933
53. Fox IH: Metabolic basis for disorders of purine nucleotide degradation. Metabolism, 1981; 30: 616-634
54. Fabregat I, Revilla E, Machado A: Short-term control of the pentose phosphate cycle by insulin could be modulated by the nadph/nadp ratio in rat adipocytes and hepatocytes. Biochem Biophys Res Commun, 1987; 146: 920-925
55. Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N: Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J, 2003; 44: 527-536
56. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ: Hyperuricemia induces endothelial dysfunction. Kidney Int, 2005; 67: 1739-1742
57. Chiou WK, Wang MH, Huang DH, Chiu HT, Lee YJ, Lin JD: The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in taiwanese. J Epidemiol, 2010; 20: 219-224
58. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, Yazici M, Keles I: Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens, 2006; 19: 1055-1062
59. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer K, Ulmer H: Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 austrian men. Clin Chem, 2008; 54: 273-284
60. Takeuchi F, Yamamoto K, Isono M, Katsuya T, Akiyama K, Ohnaka K, Rakugi H, Yamori Y, Ogihara T, Takayanagi R, Kato N: Genetic impact on uric acid concentration and hyperuricemia in the Japanese population. J Atheroscler Thromb, 2013; 20: 351-367
61. Zhang ML, Gao YX, Wang X, Chang H, Huang GW: Serum uric acid and appropriate cutoff value for prediction of metabolic syndrome among chinese adults. J Clin Biochem Nutr, 2013; 52: 38-42